Blog dermatologico

Elenco degli articoli con argomento «AAD»

nov
2017
30

Psoriasis Severity Linked to Increased Risk of Type 2 Diabetes

Rassegna stampa

People with psoriasis have a higher risk of developing type 2 diabetes than those without psoriasis, and the risk increases dramatically based on the severity of the disease, according to a study published in the Journal of the American Academy of Dermatology...

Leggi tutto
mag
2017
02

Alcohol Consumption Increases Rosacea Risk in Women

Rassegna stampa

According to new research published online in the Journal of the American Academy of Dermatology, increased consumption of alcohol, particularly white wine and liquor, is associated with a higher risk of rosacea in women....

Leggi tutto
apr
2017
28

Highlights From The 2017 AAD Annual Meeting

Comunicazioni ai soci

La SIDeMaST ha il piacere di offrire a tutti i Suoi membri gli HIGHLIGHTS FROM THE 2017 AAD ANNUAL MEETING, visibili su pc, tablet e smartphone...

Leggi tutto
apr
2017
18

Psoriasi, i linfociti impazziti che scheggiano la pelle

Rassegna stampa

Una malattia del sistema immunitario che si manifesta con placche e chiazze arrossate. Ma è lo specchio di un disturbo sistemico, scatenato da una cascata di segnali molecolari difettosi. Oggi bersaglio di terapie mirate, ed efficaci...

Leggi tutto
mar
2017
20

Certolizumab Offers Relief From Moderate-to-Severe Psoriasis

Rassegna stampa

Patients who received the targeted agent certolizumab for chronic moderate-to-severe plaque psoriasis achieved better outcomes than patients assigned to placebo -- even to the point of having nearly clear skin after 16 weeks of treatment, according to results from 2 similar phase 3 trials, reported at the 2017 Annual Meeting of the American Academy of Dermatology (AAD)...

Leggi tutto
mar
2017
20

Serlopitant Benefits Patients With Prurigo Nodularis

Rassegna stampa

The investigative agent serlopitant appears to offer some relief from the disfiguring and intensely itchy skin eruptions of prurigo nodularis, according to results of a phase 2 study presented at the 2017 Annual Meeting of the American Academy of Dermatology (AAD)...

Leggi tutto
mar
2017
20

Long-Term Treatment With Dupilumab Plus Topical Corticosteroids Controls Atopic Dermatitis

Rassegna stampa

Long-term follow-up with the investigative biologic agent dupilumab in the treatment of patients with moderate-to-severe atopic dermatitis demonstrated a significant advantage with treatment over placebo, researchers reported at the 2017 Annual Meeting of the American Academy of Dermatology (AAD)...

Leggi tutto
mar
2017
14

Dermatite atopica. Un problema anche per l'adulto e con incidenza in aumento

Rassegna stampa

Questa patologia colpisce oggi il 2-5% della popolazione. Nelle sue forme più gravi il costante prurito e le manifestazioni dei sintomi sulla pelle portano a ripercussioni psicologiche forti per i pazienti. Sanofi e Regeneron Pharmaceuticals, Inc hanno presentato un farmaco sperimentale che sembra garantire un risultato migliore rispetto alle terapie più classiche a base di cortisone....

Leggi tutto
mar
2017
14

Spray Replaces Lost Skin Bacteria, Improves Keratosis Pilaris

Rassegna stampa

A treatment that replaces natural-biome bacteria with ammonia-oxidising bacteria appears to improve the cosmetic appearance and texture of keratosis pilaris, according to results of a small phase 2 study reported at the 2017 Annual Meeting of the American Academy of Dermatology (AAD)...

Leggi tutto
mar
2017
14

Patients With Immunosuppressive Diseases/Treatments Experience Greater Complications After Mohs Surgery

Rassegna stampa

The risk of a patient having a complication following Mohs Micrographic Surgery increases if that patient has a history of immunosuppressive diseases or treatments, according to results of a 4-year retrospective, chart review presented at the 2017 Annual Meeting of the American Academy of Dermatology (AAD)...

Leggi tutto
mar
2017
14

Topical Oxymetazoline 1.0% Shows Long-Term Efficacy for Persistent Facial Erythema Associated With Rosacea

Rassegna stampa

Patients were able to tolerate treatment of their rosacea with topical 1% oxymetazoline hydrochloride gel for 1 year with acceptable reduction of redness and few adverse events, according to a study presented here at the 75th Annual Meeting of the American Academy of Dermatology (AAD)...

Leggi tutto
mar
2017
13

Ixekizumab Superior to Ustekinumab for Treating Psoriasis

Rassegna stampa

Patients with psoriasis treated with the targeted agent ixekizumab appear to have better outcomes at 24 weeks than those treated with ustekinumab, according to the 24-week data of the ongoing IXORA-S trial presented at the 2017 Annual Meeting of the American Academy of Dermatology (AAD)...

Leggi tutto
mar
2017
13

Patients Aged Older Than 85 Years Who Have Mohs Surgery Average 6 More Years of Life

Rassegna stampa

Patients aged older than 85 years can safely undergo Mohs micrographic surgery to remove non-melanoma skin cancer and still have years of good quality of life, researchers reported here at the 75th Annual Meeting of the American Academy of Dermatology (AAD)...

Leggi tutto
giu
2016
23

Grande successo degli Highlights dal 74° Congresso Annuale dell'American Academy of Dermatology

News

Illustriamo brevemente alcuni dati relativi agli Highlights dal 74° Congresso Annuale dell'American Academy of Dermatology, la cui realizzazione ha visto protagonista anche la SIDeMaST...

Leggi tutto
apr
2016
16

Highlights dal 74° Congresso Annuale dell'American Academy of Dermatology

Comunicazioni ai soci

I contenuti salienti del meeting AAD 2016, dalla dermatologia medica agli aspetti cosiddetti cosmetici, sono riportati in questi highlights...

Leggi tutto
mar
2015
28

Blood Test for Patients on Acne Medication Deemed Unnecessary

Rassegna stampa

For young, healthy women taking spironolactone to treat hormonal acne, frequent office visits and blood draws are an unnecessary health care expense...

Leggi tutto
mar
2015
28

High-Dose Brodalumab Superior to Ustekinumab in Helping Patients With Psoriasis Reach PASI 100

Rassegna stampa

At an elevated dose, brodalumab produced greater clearance of disease in patients with moderate-to-severe plaque psoriasis than the biologic therapy ustekinumab...

Leggi tutto
mar
2015
28

Adapalene/Benzoyl Peroxide for Acne Effective, Well-Tolerated After 9 Months of Use

Rassegna stampa

Adapalene 0.1%/benzoyl peroxide 2.5% (Epiduo) treatment proved to be effective and well-tolerated after 9 months of use, according to a study presented here at the 73rd Annual Meeting of the American Academy of Dermatology...

Leggi tutto
feb
2012
29

Tatuaggi e piercing, è allarme bambini in USA

Rassegna stampa

Inascoltati divieti dermatologi, boom allergie in Italia...

Leggi tutto

Eventi SIDeMaST

Stato iscrizione